左西替利嗪、孟鲁司特联合卡介菌素对慢性荨麻疹的治疗效果观察  

The therapeutic effect of levocetirizine,montelukast combined with BCG in the treatment of chronic urticaria

作　　者：余鑫海 高贵云[1] Yu Xinhai;Gao Guiyun(Dermatological Department,Hunan Aerospace Hospital,Hunan,Changsha 410005)

机构地区：[1]湖南航天医院皮肤科

出　　处：《中国社区医师》2019年第34期81-82,共2页Chinese Community Doctors

摘　　要：目的:探讨左西替利嗪、孟鲁司特联合卡介菌素对慢性荨麻疹的治疗效果。方法:2017年8月-2018年8月收治慢性荨麻疹患者68例,随机分为两组各34例。对照组采用卡介菌素干预,联合组采用卡介菌素+左西替利嗪、孟鲁司特干预。对比两组治疗控制率和不良反应发生率。结果:联合组治疗控制率明显高于对照组,且不良反应发生率低于对照组,差异均有统计学意义(P<0.05)。结论:左西替利嗪、孟鲁司特联合卡介菌素治疗慢性荨麻疹,可提高治疗控制率,降低不良反应发生率,减轻患者痛苦,值得临床应用及推广。Objective:To explore the therapeutic effect of levocetirizine,montelukast combined with BCG in the treatment of chronic urticaria.Methods:From August 2017 to August 2018,68 patients with chronic urticaria were selected and randomly divided into two groups of 34 cases in each.The control group was treated with BCG,the combined group was treated with BCG plus levocetirizine and montelukast.We compared the treatment control rate and the incidence of adverse reactions between the two groups.Results:In the combined group,the treatment control rate was significantly higher than the control group,and the incidence of complications was lower than the control group,the difference was statistically significant(P<0.05).Conclusion:The application of levocetirizine,montelukast combined with BCG in the treatment of chronic urticaria can improve the control rate of treatment,reduce the incidence of complications,and relieve the pain of patients,it was worthy of clinical application and promotion.

关 键 词：左西替利嗪 孟鲁司特 卡介菌素 慢性荨麻疹 

分 类 号：R75[医药卫生—皮肤病学与性病学]